References
- 1. Caglar S., Oztunc A.: A sensitive spectrophotometric determination of desloratadine in tablets. J. AOAC Int., 90(2), 372, 2007.
- 2. Caglar S., Toker S.E.: Simultaneous determination of desloratadine and pseudoephedrine sulphate in tablets by high performance liquid chromatography and derivative spectrophotometry. Rev. Anal. Chem. 30, 145, 2011.
- 3. El-Enany N.M., El-Sherbiny D., Belal F.: Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage form and human plasma. Chem. Pharm. Bull., 15(12), 1662, 2007.
- 4. Hasnain M.S. et al.: Development and validation of an improved LC-MS/MS method for the quantification of desloratadine and its metabolite in human plasma using deuterated desloratadine as internal standard. J. Pharm. BioAllied Sci. 5(1), 74, 2013.
- 5. http://www.tlcpharmachem.com/tlc_item.php?upc=L-1027&li=le_21&sub=L
- 6. ICH harmonized tripartite guideline: validation of analytical procedures: text and methodology, Q2 (R1), Geneva, 2005, http://www.ich.org Accessed 30 August 2013.
- 7. Mohamed G.G., Abou Attia F.M., Ibrahim N.S.: Development and validation of spectrophotometric and HPLC methods for the determination of desloratadine in tablets and syrup. J. Pharm. Res. 5(5), 2799, 2012.
- 8. Polish Farmacopeia IX, Polish Pharmaceutical Society, Warsaw, 2011.
- 9. Ponnuru V.S, Challa B.R., Nadendla R.: Quantification of desloratadine in human plasma by LC-ESI-MS/MS and application to a pharmacokinetic study. J. Pharm. Anal. 2(3), 180, 2012.
- 10. Rele R.V., Gurav P.J.: A Simple extractive spectrophotometric determination of loratadine, desloratadine and rupatadine from pharmaceutical formulations. Int. J. Pharma Bio Sci. 3(2), 89, 2012.
- 11. Renger B., Vegh Z., Ferenczi-Fodor K.: Validation of thin layer and high performance thin layer chromatographic methods. J. Chromatogr. A, 1218, 2712, 2011.
- 12. Srinubabu G. et al.: Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of loratadine and desloratadine in human plasma. J. Chromatogr. B, 860(2), 202, 2007.
- 13. Vlase L. et al.: Determination of loratadine and its active metabolite in human plasma by high- performance liquid chromatography with mass spectrometry detection. J. Pharm. Biomed. Anal. 44(3), 652, 2007.
- 14. Yang L.Y., Rudewicz P.J.: Application of new liquid chromatography - tandem mass spectrometry technologies for drug development support. J. Chromatogr. A, 926(1), 43, 2001.